| Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Productivity in Spain - Where are the Opportunities? |
|
Other Articles - Productivity in Spain - Where are the Opportunities?
A recent statistical overview presented by Eurostat , the central statistics office of the European union, presented According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product an overview about the differences in the working week between the various member states of the European Union. Ac ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ording to these statistics, the Spanish working week is -- with an average of 38.2 hours -- amongst the highest of the lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. uropean Union, only the eastern countries (like Poland and Lithuanian, etc) and Greece (39.4) have a higher working wee here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe . The average working week for the member states was calculated to be 36.3.
(http://www.elpais.es/ articulo/elppor d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro oc/20060807 elpepisoc_1/Tes/espa%C3%B1oles/est%C3%A1n/ europeos/m%C3%A1s/horas/trabajan) This means that there is ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc yet a lot of productivity to gain in Spain. A higher productivity will be possible if the amount of input (human resour easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi es) remains the same while generating a higher level of production. This is possible in a variety of ways:
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically concentrate on the business process. A wider use of information systems could help streamlining the business process, i and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ which an efficiency gain is achieved.
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi the human communication. E-mail software is a good example of a new technology that increased the productivity. The mo ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a bile phone is another, or think about the PDA for which you can send the client request directly to the kitchen, leavin dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod you more time to attend more visitors.
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ts on two sides: time and money, leaving you with additional opportunities. In Spain for example there is still a siest tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen (in some areas), which leads to four traffic congestions a day instead of two: one in the morning and one in the after t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel oon.
ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ivity enormously. There are many other ways in which the productivity could increase... All those initiative y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products will reduce the working week, but they will also reduce the social, face to face, contact between people. And that is . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de very important cultural asset in Spain. Finally, a reduced working week will increase the amount of holidays where em elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip loyees could benefit from. And when productivity rises you could very well do with an extra day off... © 2006 Hans Boo tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How To Make Money Online With Podcasting Medical Billing - HCPCS Updates
|